Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 720

1.

Identifying Mechanisms of Resistance to ALK Tyrosine Kinase Inhibitors Using Analysis of Circulating Tumor DNA.

Solomon B.

J Thorac Oncol. 2020 Apr;15(4):482-484. doi: 10.1016/j.jtho.2019.12.116. No abstract available.

PMID:
32216941
2.

Addressing the Social Needs of Spanish- and English-Speaking Families in Pediatric Primary Care.

Polk S, Leifheit KM, Thornton R, Solomon BS, DeCamp LR.

Acad Pediatr. 2020 Mar 18. pii: S1876-2859(20)30124-8. doi: 10.1016/j.acap.2020.03.004. [Epub ahead of print]

PMID:
32200111
3.

Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.

Desai J, Gan H, Barrow C, Jameson M, Atkinson V, Haydon A, Millward M, Begbie S, Brown M, Markman B, Patterson W, Hill A, Horvath L, Nagrial A, Richardson G, Jackson C, Friedlander M, Parente P, Tran B, Wang L, Chen Y, Tang Z, Huang W, Wu J, Zeng D, Luo L, Solomon B.

J Clin Oncol. 2020 Mar 17:JCO1902654. doi: 10.1200/JCO.19.02654. [Epub ahead of print]

PMID:
32182156
4.

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy.

Peters S, Kim AW, Solomon B, Gandara DR, Dziadziuszko R, Brunelli A, Garassino MC, Reck M, Wang L, To I, Sun SW, Gitlitz BJ, Sandler A, Rizvi N.

Ann Oncol. 2019 Apr;30 Suppl 2:ii30. doi: 10.1093/annonc/mdz064.014. No abstract available.

5.

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer.

Alexander M, Pavlakis N, John T, O'Connell R, Kao S, Hughes BGM, Lee A, Hayes SA, Howell VM, Clarke SJ, Millward M, Burbury K, Solomon B, Itchins M.

Lung Cancer. 2020 Apr;142:34-40. doi: 10.1016/j.lungcan.2020.01.017. Epub 2020 Jan 22.

PMID:
32087434
6.

Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma.

McDowell L, Casswell G, Bressel M, Gough K, Drosdowsky A, Coleman A, Shrestha S, D'Costa I, Fua T, Tiong A, Liu C, Ng SP, Solomon B, Rischin D.

Clin Transl Radiat Oncol. 2020 Jan 30;21:85-90. doi: 10.1016/j.ctro.2020.01.004. eCollection 2020 Mar.

7.

Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer.

Yan K, Rousseau J, Machol K, Cross LA, Agre KE, Gibson CF, Goverde A, Engleman KL, Verdin H, De Baere E, Potocki L, Zhou D, Cadieux-Dion M, Bellus GA, Wagner MD, Hale RJ, Esber N, Riley AF, Solomon BD, Cho MT, McWalter K, Eyal R, Hainlen MK, Mendelsohn BA, Porter HM, Lanpher BC, Lewis AM, Savatt J, Thiffault I, Callewaert B, Campeau PM, Yang XJ.

Sci Adv. 2020 Jan 22;6(4):eaax0021. doi: 10.1126/sciadv.aax0021. eCollection 2020 Jan.

8.

The utility of exome sequencing for fetal pleural effusions.

Jelin AC, Sobreira N, Wohler E, Solomon B, Sparks T, Sagaser KG, Forster KR, Miller J, Witmer PD, Hamosh A, Valle D, Blakemore K.

Prenat Diagn. 2020 Jan 29. doi: 10.1002/pd.5650. [Epub ahead of print]

PMID:
31994743
9.

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.

Solomon BJ, Tan L, Lin JJ, Wong SQ, Hollizeck S, Ebata K, Tuch BB, Yoda S, Gainor JF, Sequist LV, Oxnard GR, Gautschi O, Drilon A, Subbiah V, Khoo C, Zhu EY, Nguyen M, Henry D, Condroski KR, Kolakowski GR, Gomez E, Ballard J, Metcalf AT, Blake JF, Dawson SJ, Blosser W, Stancato LF, Brandhuber BJ, Andrews S, Robinson BG, Rothenberg SM.

J Thorac Oncol. 2020 Apr;15(4):541-549. doi: 10.1016/j.jtho.2020.01.006. Epub 2020 Jan 24.

10.

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.

Drilon A, Clark JW, Weiss J, Ou SI, Camidge DR, Solomon BJ, Otterson GA, Villaruz LC, Riely GJ, Heist RS, Awad MM, Shapiro GI, Satouchi M, Hida T, Hayashi H, Murphy DA, Wang SC, Li S, Usari T, Wilner KD, Paik PK.

Nat Med. 2020 Jan;26(1):47-51. doi: 10.1038/s41591-019-0716-8. Epub 2020 Jan 13.

PMID:
31932802
11.

Ethiopia: How the Care of 100 Million People Pivots on a Single Cobalt Teletherapy Machine.

Rick TJ, Habtamu B, Abreha A, Solomon B, Tigeneh W, Assefa M, Incrocci L.

Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):230-235. doi: 10.1016/j.ijrobp.2019.06.015. No abstract available.

PMID:
31928635
12.

Therapeutic Holding.

Emanuel L, Brenner KO, Spira N, Solomon B, Doolittle DB, Rosenberg L, Jackson V.

J Palliat Med. 2020 Mar;23(3):314-318. doi: 10.1089/jpm.2019.0543. Epub 2020 Jan 8.

PMID:
31913759
13.

Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma.

Young RJ, Bressel M, Porceddu S, Cernelc J, Savas P, Liu H, Urban D, Thai AA, Cooper C, Fua T, Neeson P, Rischin D, Solomon B.

Oral Oncol. 2020 Feb;101:104516. doi: 10.1016/j.oraloncology.2019.104516. Epub 2019 Dec 12.

PMID:
31838340
14.

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial.

Shaw AT, Solomon BJ, Chiari R, Riely GJ, Besse B, Soo RA, Kao S, Lin CC, Bauer TM, Clancy JS, Thurm H, Martini JF, Peltz G, Abbattista A, Li S, Ou SI.

Lancet Oncol. 2019 Dec;20(12):1691-1701. doi: 10.1016/S1470-2045(19)30655-2. Epub 2019 Oct 25.

PMID:
31669155
15.

Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.

Pavlakis N, Cooper C, John T, Kao S, Klebe S, Lee CK, Leong T, Millward M, O'Byrne K, Russell PA, Solomon B, Cooper WA, Fox S.

Pathology. 2019 Dec;51(7):673-680. doi: 10.1016/j.pathol.2019.08.006. Epub 2019 Oct 24.

PMID:
31668406
16.

First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).

Pham T, Pereira L, Roth S, Galletta L, Link E, Akhurst T, Solomon B, Michael M, Darcy P, Sampurno S, Heriot A, Ramsay R, Desai J.

Contemp Clin Trials Commun. 2019 Jul 10;16:100409. doi: 10.1016/j.conctc.2019.100409. eCollection 2019 Dec.

17.

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol.

Iravani A, Solomon B, Pattison DA, Jackson P, Ravi Kumar A, Kong G, Hofman MS, Akhurst T, Hicks RJ.

Thyroid. 2019 Nov;29(11):1634-1645. doi: 10.1089/thy.2019.0143.

PMID:
31637953
18.

Medical-Financial Partnerships: Cross-Sector Collaborations Between Medical and Financial Services to Improve Health.

Bell ON, Hole MK, Johnson K, Marcil LE, Solomon BS, Schickedanz A.

Acad Pediatr. 2020 Mar;20(2):166-174. doi: 10.1016/j.acap.2019.10.001. Epub 2019 Oct 13. Review.

PMID:
31618676
19.

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.

Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA.

Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26.

20.

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance.

Solomon B, Young RJ, Bressel M, Cernelc J, Savas P, Liu H, Urban D, Thai A, Cooper C, Fua T, Neeson P, Loi S, Porceddu SV, Rischin D.

Ann Oncol. 2019 Oct 1;30(10):1638-1646. doi: 10.1093/annonc/mdz271.

21.

The Impact of State Firearm Laws on Homicide Rates in Suburban and Rural Areas Compared to Large Cities in the United States, 1991-2016.

Siegel M, Solomon B, Knopov A, Rothman EF, Cronin SW, Xuan Z, Hemenway D.

J Rural Health. 2020 Mar;36(2):255-265. doi: 10.1111/jrh.12387. Epub 2019 Jul 30.

PMID:
31361355
22.

Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.

Morris TA, Khoo C, Solomon BJ.

Drugs. 2019 Aug;79(12):1277-1286. doi: 10.1007/s40265-019-01164-3. Review.

PMID:
31313100
23.

Disclosure of Infant Unsafe Sleep Practices by African American Mothers in Primary Care Settings.

Mahoney P, Solomon BS, McDonald EM, Shields WC, Gielen AC.

JAMA Pediatr. 2019 Jul 1. doi: 10.1001/jamapediatrics.2019.1687. [Epub ahead of print] No abstract available.

PMID:
31260002
24.

Five-parameter evaluation of dysphagia: A novel prognostic scale for assessing neurological decline in Gaucher disease type 2.

Seehra G, Solomon B, Ryan E, Steward AM, Roshan Lal T, Tanima Y, Lopez G, Sidransky E.

Mol Genet Metab. 2019 Jul;127(3):191-199. doi: 10.1016/j.ymgme.2019.06.002. Epub 2019 Jun 8.

PMID:
31256856
25.

Content of Infant Safe Sleep Counseling and Maternal Reported Practices in an Urban Clinic.

Burrell TD, McDonald EM, Mahoney P, Musci RJ, Shields W, Gielen A, Solomon BS.

Acad Pediatr. 2019 Sep - Oct;19(7):801-807. doi: 10.1016/j.acap.2019.06.014. Epub 2019 Jun 26.

PMID:
31254631
26.

Growth under intervention by means of instructional time expended: Empirical illustrations of applicable models.

Solomon BG, Poncy BC.

Sch Psychol. 2019 Sep;34(5):566-575. doi: 10.1037/spq0000327. Epub 2019 Jun 27.

PMID:
31246062
27.

Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppression.

Mardiana S, Solomon BJ, Darcy PK, Beavis PA.

Sci Transl Med. 2019 Jun 5;11(495). pii: eaaw2293. doi: 10.1126/scitranslmed.aaw2293. Review.

PMID:
31167925
28.

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.

Mazieres J, Drilon A, Lusque A, Mhanna L, Cortot AB, Mezquita L, Thai AA, Mascaux C, Couraud S, Veillon R, Van den Heuvel M, Neal J, Peled N, Früh M, Ng TL, Gounant V, Popat S, Diebold J, Sabari J, Zhu VW, Rothschild SI, Bironzo P, Martinez-Marti A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten RD, Wakelee H, Camidge DR, Zalcman G, Novello S, Ou SI, Milia J, Gautschi O.

Ann Oncol. 2019 Aug 1;30(8):1321-1328. doi: 10.1093/annonc/mdz167.

29.

Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.

Rivalland G, Mitchell P, Murone C, Asadi K, Morey AL, Starmans M, Boutros PC, Walkiewicz M, Solomon B, Wright G, Knight S, John T.

Transl Lung Cancer Res. 2019 Apr;8(2):167-175. doi: 10.21037/tlcr.2019.03.11.

30.

Mobility of Yield Stress Fluids on Lubricant-Impregnated Surfaces.

Rapoport L, Solomon BR, Varanasi KK.

ACS Appl Mater Interfaces. 2019 May 1;11(17):16123-16129. doi: 10.1021/acsami.8b21478. Epub 2019 Apr 22.

PMID:
31008574
31.

Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

Remon J, Ahn MJ, Girard N, Johnson M, Kim DW, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q.

J Thorac Oncol. 2019 Jul;14(7):1134-1155. doi: 10.1016/j.jtho.2019.03.022. Epub 2019 Apr 16. Review.

PMID:
31002952
32.

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

Shaw AT, Riely GJ, Bang YJ, Kim DW, Camidge DR, Solomon BJ, Varella-Garcia M, Iafrate AJ, Shapiro GI, Usari T, Wang SC, Wilner KD, Clark JW, Ou SI.

Ann Oncol. 2019 Jul 1;30(7):1121-1126. doi: 10.1093/annonc/mdz131.

33.

Clinical exome sequencing in 509 Middle Eastern families with suspected Mendelian diseases: The Qatari experience.

Al-Dewik N, Mohd H, Al-Mureikhi M, Ali R, Al-Mesaifri F, Mahmoud L, Shahbeck N, El-Akouri K, Almulla M, Al Sulaiman R, Musa S, Al-Marri AA, Richard G, Juusola J, Solomon BD, Alkuraya FS, Ben-Omran T.

Am J Med Genet A. 2019 Jun;179(6):927-935. doi: 10.1002/ajmg.a.61126. Epub 2019 Mar 27.

34.

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.

Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH Jr, Oh DY, Jamal R, Chee CE, Chow LQM, Gainor JF, Desai J, Solomon BJ, Das Thakur M, Pitcher B, Foster P, Hernandez G, Wongchenko MJ, Cha E, Bang YJ, Siu LL, Bendell J.

Ann Oncol. 2019 Jul 1;30(7):1134-1142. doi: 10.1093/annonc/mdz113.

35.

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.

Shaw AT, Solomon BJ, Besse B, Bauer TM, Lin CC, Soo RA, Riely GJ, Ou SI, Clancy JS, Li S, Abbattista A, Thurm H, Satouchi M, Camidge DR, Kao S, Chiari R, Gadgeel SM, Felip E, Martini JF.

J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20.

PMID:
30892989
36.

Clinical Management of Adverse Events Associated with Lorlatinib.

Bauer TM, Felip E, Solomon BJ, Thurm H, Peltz G, Chioda MD, Shaw AT.

Oncologist. 2019 Aug;24(8):1103-1110. doi: 10.1634/theoncologist.2018-0380. Epub 2019 Mar 19.

37.

Genomic and molecular characterization of preterm birth.

Knijnenburg TA, Vockley JG, Chambwe N, Gibbs DL, Humphries C, Huddleston KC, Klein E, Kothiyal P, Tasseff R, Dhankani V, Bodian DL, Wong WSW, Glusman G, Mauldin DE, Miller M, Slagel J, Elasady S, Roach JC, Kramer R, Leinonen K, Linthorst J, Baveja R, Baker R, Solomon BD, Eley G, Iyer RK, Maxwell GL, Bernard B, Shmulevich I, Hood L, Niederhuber JE.

Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5819-5827. doi: 10.1073/pnas.1716314116. Epub 2019 Mar 4.

38.

Response to Wang et al.

Roberts ME, Zeinomar N, Solomon BD, Terry MB, Chung WK.

Genet Med. 2019 Sep;21(9):2158. doi: 10.1038/s41436-019-0469-2. Epub 2019 Mar 1. No abstract available.

PMID:
30824819
39.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators.

Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.

PMID:
30770291
40.

The Other Parent: An Exploratory Survey of Providers' Engagement of Fathers in Pediatric Primary Care.

Allport BS, Solomon BS, Johnson SB.

Clin Pediatr (Phila). 2019 May;58(5):555-563. doi: 10.1177/0009922819829032. Epub 2019 Feb 14.

PMID:
30762423
41.

Synthetic Butterfly Scale Surfaces with Compliance-Tailored Anisotropic Drop Adhesion.

Zhao H, Park SJ, Solomon BR, Kim S, Soto D, Paxson AT, Varanasi KK, Hart AJ.

Adv Mater. 2019 Apr;31(14):e1807686. doi: 10.1002/adma.201807686. Epub 2019 Feb 13.

PMID:
30761627
42.

Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature.

Torti E, Keren B, Palmer EE, Zhu Z, Afenjar A, Anderson IJ, Andrews MV, Atkinson C, Au M, Berry SA, Bowling KM, Boyle J, Buratti J, Cathey SS, Charles P, Cogne B, Courtin T, Escobar LF, Finley SL, Graham JM Jr, Grange DK, Heron D, Hewson S, Hiatt SM, Hibbs KA, Jayakar P, Kalsner L, Larcher L, Lesca G, Mark PR, Miller K, Nava C, Nizon M, Pai GS, Pappas J, Parsons G, Payne K, Putoux A, Rabin R, Sabatier I, Shinawi M, Shur N, Skinner SA, Valence S, Warren H, Whalen S, Crunk A, Douglas G, Monaghan KG, Person RE, Willaert R, Solomon BD, Juusola J.

Genet Med. 2019 Sep;21(9):2036-2042. doi: 10.1038/s41436-019-0454-9. Epub 2019 Feb 11.

PMID:
30739909
43.

Promoting Bike Helmet Safety for Urban Children Through a Culturally Tailored Educational Video Intervention.

Ryan LM, Solomon BS, Ziegfeld S, Gielen A, Malloy L, Foster D, Smith KC, McDonald E.

Health Promot Pract. 2019 Jan 22:1524839918822271. doi: 10.1177/1524839918822271. [Epub ahead of print]

PMID:
30667272
44.

Radiotherapy and immunotherapy: a synergistic effect in cancer care.

Turgeon GA, Weickhardt A, Azad AA, Solomon B, Siva S.

Med J Aust. 2019 Jan;210(1):47-53. doi: 10.5694/mja2.12046. Epub 2018 Dec 12. Review.

PMID:
30636308
45.

Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers.

Cruz GI, Shao X, Quach H, Quach D, Ho KA, Sterba K, Noble JA, Patsopoulos NA, Busch MP, Triulzi DJ, Ladas N, Blasczyk R, Wong WSW, Solomon BD, Niederhuber JE, Criswell LA, Barcellos LF.

Genes Immun. 2020 Jan;21(1):27-36. doi: 10.1038/s41435-018-0055-7. Epub 2019 Jan 12.

46.

Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer.

Alexander M, Ball D, Solomon B, MacManus M, Manser R, Riedel B, Westerman D, Evans SM, Wolfe R, Burbury K.

Cancers (Basel). 2019 Jan 8;11(1). pii: E50. doi: 10.3390/cancers11010050.

47.

Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

Sutcliffe EG, Bartenbaker Thompson A, Stettner AR, Marshall ML, Roberts ME, Susswein LR, Wang Y, Klein RT, Hruska KS, Solomon BD.

Fam Cancer. 2019 Apr;18(2):203-209. doi: 10.1007/s10689-018-00116-2.

PMID:
30604180
48.

The etiology of VACTERL association: Current knowledge and hypotheses.

Solomon BD.

Am J Med Genet C Semin Med Genet. 2018 Dec;178(4):440-446. doi: 10.1002/ajmg.c.31664. Review.

PMID:
30580478
49.

The Refugee Health Partnership: A Longitudinal Experiential Medical Student Curriculum in Refugee/Asylee Health.

Bernhardt LJ, Lin S, Swegman C, Sellke R, Vu A, Solomon BS, Cuneo CN.

Acad Med. 2019 Apr;94(4):544-549. doi: 10.1097/ACM.0000000000002566.

PMID:
30570498
50.

Response to Evans et al.

Roberts ME, Zeinomar N, Solomon BD, Terry MB, Chung WK.

Genet Med. 2019 Aug;21(8):1880-1881. doi: 10.1038/s41436-018-0400-2. Epub 2018 Dec 19. No abstract available.

PMID:
30563985

Supplemental Content

Loading ...
Support Center